2004
DOI: 10.1258/000456304323019613
|View full text |Cite
|
Sign up to set email alerts
|

Faecal calprotectin: a new marker for Crohn's disease?

Abstract: Background Gastroenterologists are often hampered by the lack of a reliable, non-invasive index of bowel inflammation when establishing a differential diagnosis for patients presenting with chronic diarrhoea. Investigations aim to distinguish between inflammatory bowel disease (IBD) (e.g. Crohn's disease, ulcerative colitis) and irritable bowel syndrome (IBS). As an acute phase protein, faecal calprotectin measurement may be useful in this context.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
41
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(42 citation statements)
references
References 7 publications
1
41
0
Order By: Relevance
“…At days 3 and 6 on Salmonella infection, expression of the general inflammatory mediators Cox2, iNOS and Sod2, Pap3, Lcn, and calprotectin (S100A8 and S100A9) was strongly increased. Calprotectin, Pap 3, and Lcn are all highly expressed in the chronically inflamed mucosa of inflammatory bowel disease (IBD) patients and in animal models of this disease (6,12,23,33,58). Obviously, generic mechanisms are involved in acute inflammation due to Salmonella infection and chronic inflammation in IBD despite different pathologies.…”
Section: Discussionmentioning
confidence: 99%
“…At days 3 and 6 on Salmonella infection, expression of the general inflammatory mediators Cox2, iNOS and Sod2, Pap3, Lcn, and calprotectin (S100A8 and S100A9) was strongly increased. Calprotectin, Pap 3, and Lcn are all highly expressed in the chronically inflamed mucosa of inflammatory bowel disease (IBD) patients and in animal models of this disease (6,12,23,33,58). Obviously, generic mechanisms are involved in acute inflammation due to Salmonella infection and chronic inflammation in IBD despite different pathologies.…”
Section: Discussionmentioning
confidence: 99%
“…Quantification of either fecal calprotectin [236] or lactoferrin [128] are surrogates for the presence of fecal leukocytes [137,237]. As discussed above, the presence of the serological markers anti-Saccharomyces cerevisiae antibody and an antibody to the outer core membrane of E. coli (OmpC) have high specificity for Crohn's disease and the addition of an RNA-derived immunologically associated bacterial sequence of Pseudomonas fluorescens (I2 peptide) improves the sensitivity and specificity of the serological studies for Crohn's disease [137,237].…”
Section: Laboratory Studiesmentioning
confidence: 99%
“…Bangladesh J Med Microbiol Volume 8: Number 1 January, 2014 Discussion: An important step in the primary assessment of IBD patient is measurement of bowel inflammation as it defines the extent and severity of involvement at the beginning of treatment and during monitoring to target medical therapies and manage IBD related complications 15 . An inflammatory mediator directly released into the gut lumen from the inflammatory process might be an ideal test to detect bowel inflammation in IBD 16 . In recent studies, FC has been supposed to be a specific, sensitive, non-invasive, cheap and reliable marker for assessing intestinal inflammation 17 .The FC is stable in room temperature for at least 7 days makes it more suitable for routine clinical studies 8 .…”
Section: Resultsmentioning
confidence: 99%